2014-004543-12
Safety and Immunogenicity of Two 0.25 mL or 0.5 mL Doses of Two Different Influenza Vaccines in Healthy Children Aged 6 to <60 Months.
Novartis Vaccines and Diagnostics Srl.·EU Clinical Trials Register
Study focus
- Disease/Condition
- Influenza
Sponsor & location
- Primary sponsor
- Novartis Vaccines and Diagnostics Srl.
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
Primary outcome
• Number and percentage of children with at least one local or systemic reaction between 1 and 7 days after any vaccine injection.
ICD-10 classifications
Influenza and pneumoniaInfluenza due to identified seasonal influenza virusInfluenza with other manifestations, seasonal influenza virus identifiedInfluenza with pneumonia, seasonal influenza virus identifiedInfluenza due to identified zoonotic or pandemic influenza virus
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2014-004543-12
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2014-004543-12 through Pure Global AI's free database. This phase not specified trial is sponsored by Novartis Vaccines and Diagnostics Srl. and is currently status unknown. The study focuses on Influenza.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.